The first in-human, phase 1, randomized, double-blind,
placebo-controlled study conducted to determine the safety,
tolerability, and pharmacokinetics of single and multiple ascending
oral doses of molnupiravir in healthy subjects.
About the Podcast
We take the most popularly asked clinical questions monthly and create a class around the corresponding evidence. Our EBM podcast will offer a glimpse into the evidence covered, and listeners can follow up with our CE if interested in more information.